Skip to main content
. 2020 Feb 10;39:32. doi: 10.1186/s13046-019-1511-6

Table 2.

Association of miR-15b-3p Expression in GC with Different Clinicopathological Features

Variables Exo-miR-15b-3p expression P-value
Low(n = 54) High(n = 54)
Age, years 0.425
 <60 22(40.7%) 18(33.3%)
 ≥ 60 32(59.3%) 36(66.7%)
Gender 0.661
 Male 41(75.9%) 39(72.2%)
 Female 13(24.1%) 15(27.8%)
Smoking 0.311
 Yes 16(29.6%) 21(38.9%)
 No 38(70.4%) 33(61.1%)
Alcohol abuse 0.024*
 Yes 8(14.8%) 18(33.3%)
 No 46(85.2%) 36(66.7%)
Family history of cancer 0.206
 Yes 7(13.0%) 12(22.2%)
 No 47(87.0%) 42(77.8%)
Size, cm 0.020*
 <3.5 30(55.6%) 18(33.3%)
 ≥ 3.5 24(44.4%) 36(66.7%)
Location 0.267
 Cardia 16(29.6%) 11(20.4%)
 Non-cardia 38(70.4%) 43(79.6%)
Lauren’s classification 0.101
 Intestinal type 22(40.7%) 14(25.9%)
 Diffuse type 20(37.0%) 31(57.4%)
 Mixed type 12(22.2%) 9(16.7%)
Histological grade 0.011*
 Well differentiated 22(40.7%) 10(18.5%)
 Poor differentiated 32(59.3%) 44(81.5%)
Invasion depth 0.176
 T1/2 28(51.9%) 21(38.9%)
 T3/4 26(48.1%) 33(61.1%)
Tumor stage 0.002*
 I,II 38(70.4%) 22(40.7%)
 III,IV 16(29.6%) 32(59.3%)
Lymphovascular invasion 0.001*
 Negative 37(68.5%) 20(37.0%)
 Positive 17(31.5%) 34(63.0%)

*P < 0.05